- Generic Name: Cabozantinib
- Strength: 20 mg and 80 mg
- Manufactured: AstraZeneca Pharmaceuticals LP
Cabozantinib is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
What is the generic name of Cometriq?
The generic name of Cometriq is Cabozantinib.
Who is the manufacturer of Cometriq?
Cometriq is manufactured by AstraZeneca Pharmaceuticals LP
Is Cabozantinib approved by Europe?
Yes, Cabozantinib is approved in Europe by brand name of Cabometyx.
What is the dosage form of Cometriq?
Cometriq is available as 20 mg and 80 mg capsules.
Prescribing information of Cometriq?
Click Here to download full prescribing information.
What are the storage conditions of Cometriq (Cabozantinib)?
Cometriq (Cabozantinib) should be Stored at controlled room temperature, 20°C to 25°C (68°F to 77°F); excursions are permitted from 15°C to 30°C (59°F to 86°F)
How Cometriq (Cabozantinib) Capsules is supplied?
Cometriq (Cabozantinib) is available as 20 mg and 80 mg.
How does Cometriq work?
Cabozantinib is a type of targeted therapy drug called a tyrosine kinase inhibitor. It works by blocking (inhibiting) the signals inside cancer cells that make them grow and divide. This may help to stop or slow down the growth of the cancer. It can also stop new blood vessels growing in the area of the cancer. Cancer cells need to make new blood vessels so they can grow and spread.
About Cometriq (Cabozantinib) Medicine.
Cometriq (Cabozantinib) is sold under the brand-name Cabometyx and Cometriq. It is in the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma among others. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET.
What is Cometriq (Cabozantinib) used for?
Cometriq (Cabozantinib) is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC)
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.